Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw
Latest AUM
₹ 858.9 Cr.
NAV as on 29 may, 2026
₹ 21.82
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 29 may, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.42% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.89% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.60% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.60% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.96% |
Debt & Credit Risk Analysis
| Alpha | -0.54% |
| Beta | 0.92% |
| Sharpe Ratio | 0.99% |
| Standard Deviation | 16.03% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 5.83% | NA | 6.12% |
| 6 Months | 5.59% | NA | 12.92% |
| 9 Months | 7.10% | NA | 4.47% |
| 1 Year | 10.61% | 10.61% | 6.04% |
| 2 Years | 26.18% | 12.33% | 24.93% |
| 3 Years | 89.65% | 23.78% | 25.71% |
| 5 Years | 81.33% | 12.64% | 19.91% |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw is one Equity mutual fund offered by Aditya Birla Sun Life Mutual Fund. Launched on 10 Jul 2019, the fund aims Long term capital growth. investments in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. It manages assets worth ₹858.9 crore as on Tue Mar 31, 2026. The expense ratio stands at 2.3%.
Dhaval Joshi has experience Prior to joining Aditya Birla Sun Life Mutual Fund, he was associated with Sundaram Mutual Fund, Emkay Global Financial Services and Asit C Mehta Investment Intermediates Ltd..
Dhaval Shah has experience Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Aditya Birla Sun Life Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth | 858.9 | +4.52% | +5.83% | +5.59% | +10.61% | +23.78% | +12.64% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth | 858.9 | +4.65% | +6.19% | +6.35% | +12.13% | +25.47% | +14.23% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw | 858.9 | +4.65% | +6.19% | +6.35% | +12.13% | +25.47% | +14.23% |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth | 73.1 | +3.18% | +3.48% | +2.52% | +11.28% | +24.07% | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +3.19% | +3.74% | +2.99% | +6.71% | +23.69% | +13.80% |
| Nippon India Pharma Fund-growth | 7,898.2 | +3.12% | +3.52% | +2.54% | +5.76% | +22.58% | +12.78% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +3.12% | +3.52% | +2.54% | +5.76% | +22.58% | +12.78% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +3.19% | +3.74% | +2.99% | +6.71% | +23.69% | +13.80% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +3.64% | +7.69% | +2.60% | +8.34% | +28.46% | +16.82% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +3.58% | +7.47% | +2.17% | +7.45% | +27.38% | +15.79% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +3.64% | +7.69% | +2.60% | +8.34% | +28.46% | +16.82% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +3.58% | +7.47% | +2.17% | +7.45% | +27.38% | +15.79% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +4.57% | +6.47% | +5.13% | +9.87% | +24.76% | +15.50% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.65% | +6.73% | +5.65% | +10.99% | +26.07% | +16.73% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹44.93 | +28.46% | +16.82% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹27.14 | +28.46% | +16.82% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹530.58 | +26.07% | +16.73% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹368.63 | +26.07% | +16.73% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹47.19 | +26.91% | +16.10% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹28.42 | +26.91% | +16.10% | — |
| Dsp Healthcare Fund Direct-growth | ₹45.57 | +24.23% | +15.83% | — |
| Dsp Healthcare Fund Direct-idcw | ₹26.35 | +24.23% | +15.83% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | ₹41.41 | +27.38% | +15.79% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | ₹24.16 | +27.38% | +15.79% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 29 May 2026 | ₹21.82 |
| 27 May 2026 | ₹22.10 |
| 25 May 2026 | ₹22.22 |
| 22 May 2026 | ₹22.13 |
| 21 May 2026 | ₹22.31 |
| 20 May 2026 | ₹22.24 |
| 19 May 2026 | ₹22.24 |
| 18 May 2026 | ₹22.16 |
| 15 May 2026 | ₹22.16 |
| 14 May 2026 | ₹22.11 |
| 13 May 2026 | ₹21.65 |
| 12 May 2026 | ₹21.61 |
| 11 May 2026 | ₹22.02 |
| 08 May 2026 | ₹21.84 |
| 07 May 2026 | ₹21.72 |
| 06 May 2026 | ₹21.64 |
| 05 May 2026 | ₹21.21 |
| 04 May 2026 | ₹21.17 |
| 30 Apr 2026 | ₹20.88 |
| 29 Apr 2026 | ₹20.90 |
| 28 Apr 2026 | ₹20.83 |
| 27 Apr 2026 | ₹20.92 |
| 24 Apr 2026 | ₹20.48 |
| 23 Apr 2026 | ₹20.72 |
| 22 Apr 2026 | ₹20.49 |
| 21 Apr 2026 | ₹20.43 |
| 20 Apr 2026 | ₹20.41 |
| 17 Apr 2026 | ₹20.45 |
| 16 Apr 2026 | ₹20.35 |
| 15 Apr 2026 | ₹20.40 |
Portfolio Updated on: 30 May, 2026
Fund Growth & Size Analysis
Compare Mutual funds
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw Returns Comparison
Compare Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw with any MF,
EYF, stock or index
No funds found for your search.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw FAQ'S
- Sharpe Ratio: 0.99%
- Standard Deviation: 16.03%
- Beta: 0.92%
- Alpha: -0.54%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw stand at approximately ₹ 858.9 crore.
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw has delivered the following short-term performance:
- 3 Months Return: 5.83%
- 6 Months Return: 5.59%
The historical growth of the Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 23.78%
- 5 Year CAGR: 12.64%
- Return Since Launch: 18.94%
The portfolio of Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw is distributed across different asset classes as follows:
- Equity: 98.61%
- Other Assets: 1.39%
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw is managed by Dhaval Shah, representing Aditya Birla Sun Life Mutual Fund.
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.42% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.34% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.89% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.60% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.60% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.96% of the portfolio
Major sector exposures in Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw are:
- Healthcare – accounts for 981.29% of the portfolio
- Industrials – accounts for 15.39% of the portfolio
- Materials – accounts for 9.86% of the portfolio
